Related Experiment Video
Updated: Jun 12, 2025
05:05
Ultrasound Cyclo Plasty in Eyes with Glaucoma
Published on: January 26, 2018
12.1K
LASER PHOTOCOAGULATION TREATMENT FOR CANDIDA CHORIORETINITIS
Robin C Su1, Ankur Mehra, Tsun-Kang Chiang
1Department of Ophthalmology and Visual Sciences, University Hospitals Eye Institute, Case Western Reserve University, Cleveland, Ohio.
Retinal Cases & Brief Reports
|September 26, 2024
Summary
Laser photocoagulation offers a novel treatment for refractory Candida chorioretinitis, a fungal eye infection resistant to standard antifungal therapies. This approach successfully resolved lesions in an immunosuppressed patient, showing sustained resolution for over a year.
Area of Science:
- Ophthalmology
- Medical Mycology
Background:
- Candida chorioretinitis is a serious fungal infection of the retina and choroid.
- Cases refractory to systemic and intravitreal antifungal medications present a significant clinical challenge.
- Limited therapeutic options exist for resistant fungal ocular infections.
Purpose of the Study:
- To describe a novel surgical technique using laser photocoagulation for managing Candida chorioretinal lesions.
- To present an alternative treatment for fungal eye infections unresponsive to conventional antifungal drugs.
Main Methods:
- Argon laser photocoagulation was applied directly to and around a Candida chorioretinal lesion.
- The patient was immunosuppressed and had failed extensive medical therapy.
Main Results:
- The Candida chorioretinal lesion resolved completely after laser photocoagulation.
- Sustained resolution was observed for over one year without recurrence, lesion extension, or satellite formation.
Conclusions:
- Candida chorioretinitis can be highly resistant to standard antifungal treatments.
- Laser photocoagulation represents a potential novel therapeutic option for refractory cases.
- This technique may offer a valuable alternative when medical management fails.
Keywords:
laser photocoagulation
